A RASSF1A-HIF1α loop drives Warburg effect in cancer and pulmonary hypertension
Swati Dabral(University of Würzburg), Soni Savai Pullamsetti(Justus-Liebig-Universität Gießen), Werner Seeger(Justus-Liebig-Universität Gießen), Christos Samakovlis(Stockholm University), Michael Meister(German Center for Lung Research), Mario Schmoranzer(Max Planck Institute for Heart and Lung Research), Gregg L. Semenza(Johns Hopkins University), Christian Muecke(Max Planck Institute for Heart and Lung Research), Norbert Weißmann(Cardio-Pulmonary Institute), Rajkumar Savai(Goethe University Frankfurt), Tamina Seeger‐Nukpezah(University of Cologne), Astrid Wietelmann(Max Planck Institute for Heart and Lung Research), Friedrich Grimminger(Justus-Liebig-Universität Gießen), Thomas Muley(German Center for Lung Research), Chanil Valasarajan(Universities of Giessen and Marburg Lung Center)
Cited by 107
Related Papers
Clinical classification of pulmonary hypertension
|Journal of the American College of Cardiology|2004|1.9k
Inhaled Iloprost for Severe Pulmonary Hypertension
|New England Journal of Medicine|2002|1.8k
Riociguat for the Treatment of Chronic Thromboembolic Pulmonary Hypertension
|New England Journal of Medicine|2013|1.4k
FIH-1: a novel protein that interacts with HIF-1α and VHL to mediate repression of HIF-1 transcriptional activity
|Genes & Development|2001|1.4k
HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations
|Journal of Clinical Investigation|2013|1.3k